Literature DB >> 19021832

Rheolytic thrombectomy for dural venous sinus thrombosis.

Kalgi Modi1, Vijay Misra, Pratap Reddy.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral venous thrombosis is a rare condition. Its diagnosis and management can be difficult. Treatment options include systemically delivered anticoagulation or thrombolysis. Intrasinus thrombolysis is an increasingly used intervention but it increases the risk of hemorrhage, especially in patients who have a rapidly deteriorating neurological condition. Mechanical thrombectomy that provides rapid canalization without increased risk of hemorrhage is an attractive alternative treatment.
METHODS: We describe the use of AngioJet rheolytic thrombectomy in 4 patients with extensive cerebral venous sinus thrombosis, preexisting intracranial hemorrhage, and severe progressive neurological deficit despite heparin therapy.
RESULTS: Partial or complete sinus patency was restored in all 4 patients and complete neurological recovery was achieved in 3 patients.
CONCLUSION: Intracranial hemorrhage or a rapidly deteriorating neurological condition may preclude the use of thrombolytic agents in the treatment of patients with cerebral venous sinus thrombosis. In such patients, mechanical thrombectomy offers a useful alternative.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19021832     DOI: 10.1111/j.1552-6569.2008.00311.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  3 in total

Review 1.  Intracerebral hemorrhage from cerebral venous thrombosis.

Authors:  Jitphapa Pongmoragot; Gustavo Saposnik
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

2.  Solitaire FR device for treatment of dural sinus thrombosis.

Authors:  Bryan Anthony Pukenas; Monisha Kumar; Michael Stiefel; Michelle Smith; Robert Hurst
Journal:  BMJ Case Rep       Date:  2012-12-19

3.  Mechanical thrombectomy versus intrasinus thrombolysis for cerebral venous sinus thrombosis: a non-randomized comparison.

Authors:  Fazeel M Siddiqui; Chirantan Banerjee; Susanna M Zuurbier; Qing Hao; Chul Ahn; Glenn L Pride; Muhammad Wasay; Charles Blm Majoie; David Liebeskind; Mark Johnson; Jan Stam
Journal:  Interv Neuroradiol       Date:  2014-06-17       Impact factor: 1.610

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.